GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biovica International AB (OSTO:BIOVIC B) » Definitions » Days Sales Outstanding

Biovica International AB (OSTO:BIOVIC B) Days Sales Outstanding : 139.93 (As of Jan. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Biovica International AB Days Sales Outstanding?

Biovica International AB's average Accounts Receivable for the three months ended in Jan. 2024 was kr1.65 Mil. Biovica International AB's Revenue for the three months ended in Jan. 2024 was kr1.08 Mil. Hence, Biovica International AB's Days Sales Outstanding for the three months ended in Jan. 2024 was 139.93.

The historical rank and industry rank for Biovica International AB's Days Sales Outstanding or its related term are showing as below:

OSTO:BIOVIC B' s Days Sales Outstanding Range Over the Past 10 Years
Min: 7.51   Med: 72.45   Max: 378.32
Current: 71.83

During the past 9 years, Biovica International AB's highest Days Sales Outstanding was 378.32. The lowest was 7.51. And the median was 72.45.

OSTO:BIOVIC B's Days Sales Outstanding is ranked better than
50.84% of 889 companies
in the Biotechnology industry
Industry Median: 72.66 vs OSTO:BIOVIC B: 71.83

Biovica International AB's Days Sales Outstanding increased from Jan. 2023 (76.32) to Jan. 2024 (139.93).


Biovica International AB Days Sales Outstanding Historical Data

The historical data trend for Biovica International AB's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biovica International AB Days Sales Outstanding Chart

Biovica International AB Annual Data
Trend Apr15 Apr16 Apr17 Apr18 Apr19 Apr20 Apr21 Apr22 Apr23
Days Sales Outstanding
Get a 7-Day Free Trial Premium Member Only 170.05 378.32 39.01 120.57 92.01

Biovica International AB Quarterly Data
Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
Days Sales Outstanding Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 76.32 55.64 61.41 75.58 139.93

Competitive Comparison of Biovica International AB's Days Sales Outstanding

For the Biotechnology subindustry, Biovica International AB's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Biovica International AB's Days Sales Outstanding Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Biovica International AB's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Biovica International AB's Days Sales Outstanding falls into.



Biovica International AB Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Biovica International AB's Days Sales Outstanding for the fiscal year that ended in Apr. 2023 is calculated as

Days Sales Outstanding (A: Apr. 2023 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Apr. 2022 ) + Accounts Receivable (A: Apr. 2023 )) / count ) / Revenue (A: Apr. 2023 )*Days in Period
=( (1.129 + 0.577) / 2 ) / 3.384*365
=0.853 / 3.384*365
=92.01

Biovica International AB's Days Sales Outstanding for the quarter that ended in Jan. 2024 is calculated as:

Days Sales Outstanding (Q: Jan. 2024 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Oct. 2023 ) + Accounts Receivable (A: Jan. 2024 )) / count ) / Revenue (A: Jan. 2024 )*Days in Period
=( (2.462 + 0.835) / 2 ) / 1.075*365 / 4
=1.6485 / 1.075*365 / 4
=139.93

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Biovica International AB  (OSTO:BIOVIC B) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.


Biovica International AB Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Biovica International AB's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.


Biovica International AB (OSTO:BIOVIC B) Business Description

Traded in Other Exchanges
Address
Dag Hammarskjolds vag 54B, Uppsala Science Park, Uppsala, SWE, 752 37
Biovica International AB is a biotech company. It develops and commercializes blood-based diagnostic tests with biomarkers that improve monitoring and evaluation of modern cancer treatments. Through collaboration with world- leading cancer institutes and pharmaceutical companies, it promotes the trend in healthcare for personalized treatment, with a primary focus on patient survival and benefits to society. DiviTum is manufactured by the company and sold as a kit consisting of a reaction plate with reagents that have been optimized for ELISA applications.

Biovica International AB (OSTO:BIOVIC B) Headlines

No Headlines